4//SEC Filing
Lawton Alison Frances 4
Accession 0001209191-20-064066
CIK 0001636282other
Filed
Dec 16, 7:00 PM ET
Accepted
Dec 17, 4:33 PM ET
Size
5.5 KB
Accession
0001209191-20-064066
Insider Transaction Report
Form 4
LAWTON ALISON FRANCIS
Director
Transactions
- Award
Director Stock Option (right to buy)
2020-12-15+47,200→ 47,200 totalExercise: $9.09Exp: 2030-12-14→ Common Stock (47,200 underlying)
Footnotes (1)
- [F1]The stock option vests and becomes exercisable in 36 equal monthly installments beginning on January 15, 2021 until such time as the option is 100% vested, subject to the continuing service of the Reporting Person on each vesting date.
Documents
Issuer
Aeglea BioTherapeutics, Inc.
CIK 0001636282
Entity typeother
Related Parties
1- filerCIK 0001542650
Filing Metadata
- Form type
- 4
- Filed
- Dec 16, 7:00 PM ET
- Accepted
- Dec 17, 4:33 PM ET
- Size
- 5.5 KB